Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Peroxiredoxin 1 Contributes to Host Defenses against Mycobacterium tuberculosis.

Matsumura K, Iwai H, Kato-Miyazawa M, Kirikae F, Zhao J, Yanagawa T, Ishii T, Miyoshi-Akiyama T, Funatogawa K, Kirikae T.

J Immunol. 2016 Oct 15;197(8):3233-3244. Epub 2016 Sep 7.

2.

A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis.

Watanabe S, Matsumura K, Iwai H, Funatogawa K, Haishima Y, Fukui C, Okumura K, Kato-Miyazawa M, Hashimoto M, Teramoto K, Kirikae F, Miyoshi-Akiyama T, Kirikae T.

Infect Immun. 2016 Jul 21;84(8):2264-2273. doi: 10.1128/IAI.00417-16. Print 2016 Aug.

3.

MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection.

Iwai H, Funatogawa K, Matsumura K, Kato-Miyazawa M, Kirikae F, Kiga K, Sasakawa C, Miyoshi-Akiyama T, Kirikae T.

Tuberculosis (Edinb). 2015 May;95(3):246-50. doi: 10.1016/j.tube.2015.03.006. Epub 2015 Mar 21.

PMID:
25846955
4.

Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.

Sekiguchi J, Nakamura T, Miyoshi-Akiyama T, Kirikae F, Kobayashi I, Augustynowicz-Kopec E, Zwolska Z, Morita K, Suetake T, Yoshida H, Kato S, Mori T, Kirikae T.

J Clin Microbiol. 2007 Sep;45(9):2802-7. Epub 2007 Jun 27.

5.

Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction.

Hashimoto M, Furuyashiki M, Kaseya R, Fukada Y, Akimaru M, Aoyama K, Okuno T, Tamura T, Kirikae T, Kirikae F, Eiraku N, Morioka H, Fujimoto Y, Fukase K, Takashige K, Moriya Y, Kusumoto S, Suda Y.

Infect Immun. 2007 Apr;75(4):1926-32. Epub 2007 Feb 5.

6.

Detection of multidrug resistance in Mycobacterium tuberculosis.

Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopeć E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, Kuratsuji T, Mori T, Kirikae T.

J Clin Microbiol. 2007 Jan;45(1):179-92. Epub 2006 Nov 15.

7.

Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents.

Huang Q, Kirikae F, Kirikae T, Pepe A, Amin A, Respicio L, Slayden RA, Tonge PJ, Ojima I.

J Med Chem. 2006 Jan 26;49(2):463-6.

8.

Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population.

Itoyama S, Keicho N, Hijikata M, Quy T, Phi NC, Long HT, Ha LD, Ban VV, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T.

Am J Med Genet A. 2005 Jul 1;136(1):52-7.

PMID:
15937940
9.

Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population.

Hamano E, Hijikata M, Itoyama S, Quy T, Phi NC, Long HT, Ha LD, Ban VV, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T, Keicho N.

Biochem Biophys Res Commun. 2005 Apr 22;329(4):1234-9.

PMID:
15766558
10.

Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long-lasting immunity.

Shichijo S, Keicho N, Long HT, Quy T, Phi NC, Ha LD, Ban VV, Itoyama S, Hu CJ, Komatsu N, Kirikae T, Kirikae F, Shirasawa S, Kaji M, Fukuda T, Sata M, Kuratsuji T, Itoh K, Sasazuki T.

Tissue Antigens. 2004 Nov;64(5):600-7.

PMID:
15496204
11.

Characterization of a trinucleotide repeat sequence (CGG)5 and potential use in restriction fragment length polymorphism typing of Mycobacterium tuberculosis.

Otsuka Y, Parniewski P, Zwolska Z, Kai M, Fujino T, Kirikae F, Toyota E, Kudo K, Kuratsuji T, Kirikae T.

J Clin Microbiol. 2004 Aug;42(8):3538-48.

12.

Role of the complement-lectin pathway in anaphylactoid reaction induced with lipopolysaccharide in mice.

Swierzko AS, Cedzyński M, Kirikae T, Nakano M, Klink M, Kirikae F, Ziółkowski A, Vinogradov EV, Kawakami M.

Eur J Immunol. 2003 Oct;33(10):2842-52.

13.

Structure-activity relationship study of taxoids for their ability to activate murine macrophages as well as inhibit the growth of macrophage-like cells.

Ojima I, Fumero-Oderda CL, Kuduk SD, Ma Z, Kirikae F, Kirikae T.

Bioorg Med Chem. 2003 Jul 3;11(13):2867-88.

PMID:
12788358
14.

Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice.

Funatogawa K, Ide T, Kirikae F, Saruta K, Nakano M, Kirikae T.

Microbiol Immunol. 2002;46(11):761-6.

15.

Fungal Infection in Neutropenic Patients in a Hospital during Construction.

Yonemori K, Takezako N, Nishimura K, Onose T, Yamanishi F, Kawahata H, Kawana A, Mori N, Kirikae F, Saruta K, Kirikae T, Kuratsuji T, Kudo K, Kobori O, Yazaki Y, Miwa T.

Jpn J Infect Dis. 2002 Aug;55(4):126-7. No abstract available.

PMID:
12403910
16.

Structural study on lipid A and the O-specific polysaccharide of the lipopolysaccharide from a clinical isolate of Bacteroides vulgatus from a patient with Crohn's disease.

Hashimoto M, Kirikae F, Dohi T, Adachi S, Kusumoto S, Suda Y, Fujita T, Naoki H, Kirikae T.

Eur J Biochem. 2002 Aug;269(15):3715-21.

17.

Non-standard biological activities of lipopolysaccharide from Helicobacter pylori.

Matsuyama N, Kirikae T, Kirikae F, Hashimoto M, Amanot K, Hayashi S, Hirai Y, Kubota T, Nakano M.

J Med Microbiol. 2001 Oct;50(10):865-9.

PMID:
11599735
18.

Protective effect of OK-432 on mice against endotoxemia and infection with Pseudomonas aeruginosa and Salmonella enteritidis.

Hashimoto M, Kirikae F, Toyooka K, Kaneko A, Yamasu H, Iwai H, Nakano M, Kirikae T.

Microbiol Immunol. 2001;45(6):425-32.

19.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a hospital in Chiang Mai.

Tharavichitkul P, Fujino T, Mori N, Kaneko A, Kirikae F, Sirisanthana T, Kirikae T.

Jpn J Infect Dis. 2001 Apr;54(2):82-3. No abstract available.

PMID:
11427751
20.

Structural elucidation of a capsular polysaccharide from a clinical isolate of Bacteroides vulgatus from a patient with Crohn's disease.

Hashimoto M, Kirikae F, Dohi T, Kusumoto S, Suda Y, Kirikae T.

Eur J Biochem. 2001 Jun;268(11):3139-44.

21.

Quinolactacins A, B and C: novel quinolone compounds from Penicillium sp. EPF-6. I. Taxonomy, production, isolation and biological properties.

Kakinuma N, Iwai H, Takahashi S, Hamano K, Yanagisawa T, Nagai K, Tanaka K, Suzuki K, Kirikae F, Kirikae T, Nakagawa A.

J Antibiot (Tokyo). 2000 Nov;53(11):1247-51.

22.
24.

Epidemiological analysis of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit after cleaning of environmental surfaces in the unit by genomic DNA fingerprinting using pulsed-field gel electrophoresis.

Kaneko A, Miyazawa H, Kirikae F, Hashimoto M, Toyooka K, Ishii Y, Suzuki T, Hasegawa M, Kuratsuji T, Sumiya M, Kudo K, Kobori O, Yazaki Y, Kirikae T.

Jpn J Infect Dis. 2000 Jun;53(3):130-1. No abstract available.

PMID:
10957713
25.
26.

Epidemiological analysis of a methicillin-resistant Staphylococcus aureus outbreak in a surgery ward by genomic DNA fingerprinting using pulsed-field gel electrophoresis.

Kaneko A, Kimura S, Kirikae F, Toyooka K, Hashimoto M, Hasegawa M, Mezaki K, Kuratsuji T, Sumiya M, Kobori O, Yazaki Y, Kirikae T.

Jpn J Infect Dis. 2000 Apr;53(2):84-5. No abstract available.

PMID:
10871926
27.

Epidemiological analysis of methicillin-resistant Staphylococcus aureus outbreaks in a neonatal intensive care unit by genomic DNA fingerprinting using pulsed-field gel electrophoresis.

Kaneko A, Miyazawa H, Kirikae F, Toyooka K, Hashimoto M, Yamasaki S, Hasegawa M, Takeuchi C, Kuratsuji T, Sumiya M, Kobori O, Yazaki Y, Kirikae T.

Jpn J Infect Dis. 2000 Apr;53(2):82-4. No abstract available.

PMID:
10871925
28.

Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide.

St Swierzko A, Kirikae T, Kirikae F, Hirata M, Cedzynski M, Ziolkowski A, Hirai Y, Kusumoto S, Yokochi T, Nakano M.

J Med Microbiol. 2000 Feb;49(2):127-38.

PMID:
10670563
29.

Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2.

Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M, Miyake K.

Biochem Biophys Res Commun. 2000 Feb 5;268(1):172-7.

PMID:
10652232
30.

Effect of Pseudomonas aeruginosa exotoxin A on endotoxin-induced tumour necrosis factor production in murine lung.

Hirakata Y, Kirikae T, Kirikae F, Yamaguchi T, Izumikawa K, Takemura H, Maesaki S, Tomono K, Yamada Y, Kamihira S, Nakano M, Kitamura S, Kohno S.

J Med Microbiol. 1999 May;48(5):471-7.

PMID:
10229544
31.
32.

Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli.

Kirikae T, Kirikae F, Saito S, Tominaga K, Tamura H, Uemura Y, Yokochi T, Nakano M.

Antimicrob Agents Chemother. 1998 May;42(5):1015-21.

33.

Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.

Kirikae T, Ojima I, Ma Z, Kirikae F, Hirai Y, Nakano M.

Biochem Biophys Res Commun. 1998 Apr 28;245(3):698-704.

PMID:
9588177
34.

The role of scavenger receptors in LPS-induced macrophage activation.

Kirikae T, Kodama T, Kirikae F, Suzuki H, Nakano M.

Prog Clin Biol Res. 1998;397:97-105. No abstract available.

PMID:
9575551
35.

Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia.

Kirikae T, Hirata M, Yamasu H, Kirikae F, Tamura H, Kayama F, Nakatsuka K, Yokochi T, Nakano M.

Infect Immun. 1998 May;66(5):1861-8.

36.

Endotoxin contamination in fetal bovine serum and its influence on tumor necrosis factor production by macrophage-like cells J774.1 cultured in the presence of the serum.

Kirikae T, Tamura H, Hashizume M, Kirikae F, Uemura Y, Tanaka S, Yokochi T, Nakano M.

Int J Immunopharmacol. 1997 May;19(5):255-62.

PMID:
9439764
37.

Participation of CD14 in the phagocytosis of smooth-type Salmonella typhimurium by the macrophage-like cell line, J774.1.

Onozuka K, Kirikae T, Kirikae F, Suda Y, Kusumoto S, Yamamoto S, Shimamura T, Nakano M.

Microbiol Immunol. 1997;41(10):765-72.

38.

Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages.

Kirikae T, Ojima I, Kirikae F, Ma Z, Kuduk SD, Slater JC, Takeuchi CS, Bounaud PY, Nakano M.

Biochem Biophys Res Commun. 1996 Oct 3;227(1):227-35.

PMID:
8858130
40.

Macrophage activation in response to S-form lipopolysaccharides (LPS) separated by centrifugal partition chromatography from wild-type LPS: effects of the O-polysaccharide portion of LPS.

Suda Y, Kirikae T, Shiyama T, Yasukochi T, Kirikae F, Nakano M, Rietschel ET, Kusumoto S.

Biochem Biophys Res Commun. 1995 May 25;210(3):678-85.

PMID:
7763241
41.
42.

Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells.

Kirikae T, Schade FU, Kirikae F, Qureshi N, Takayama K, Rietschel ET.

FEMS Immunol Med Microbiol. 1994 Sep;9(3):237-43.

PMID:
7812271
43.

The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction.

Kirikae T, Schade FU, Zähringer U, Kirikae F, Brade H, Kusumoto S, Kusama T, Rietschel ET.

FEMS Immunol Med Microbiol. 1994 Jan;8(1):13-26.

PMID:
8156049
44.

Biological activity of lipid A partial structures.

Ulmer AJ, Heine H, Feist W, Wang MH, Loppnow H, Kirikae T, Kirikae F, Kusumoto S, Kusama T, Brade H, et al.

Prog Clin Biol Res. 1994;388:71-83. Review. No abstract available.

PMID:
7831377
45.

The receptor(s) for endotoxin on mammalian cells.

Morrison DC, Kirikae T, Kirikae F, Lei MG, Chen T, Vukajlovich SW.

Prog Clin Biol Res. 1994;388:3-15. No abstract available.

PMID:
7530368
46.
47.

Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide.

Ulmer AJ, Feist W, Heine H, Kirikae T, Kirikae F, Kusumoto S, Kusama T, Brade H, Schade U, Rietschel ET, et al.

Infect Immun. 1992 Dec;60(12):5145-52.

48.

Detection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophage-like cell lines.

Kirikae T, Kirikae F, Schade FU, Yoshida M, Kondo S, Hisatsune K, Nishikawa S, Rietschel ET.

FEMS Microbiol Immunol. 1991 Nov;3(6):327-36.

PMID:
1725955

Supplemental Content

Loading ...
Support Center